Overview
News
Salaries
Products
People
Growth
Offices
Financials
Portfolio
Companies
104
41 of them startups
Hiring now
16
companies with open roles
Rounds in 12 months
6
$366M raised
Its companies, the freshest money firstAll in Startups
IngenixSeed $14M · 3 mo ago
Mediar TherapeuticsSeries B $76M · 8 mo ago
Latent LabsVenture round $50M · 19 mo ago · 7 roles
BioptimusVenture round $41M · 20 mo ago · 9 roles
Elicit PlantSeries B $48.6M · 22 mo ago
Noema PharmaSeries B · 22 mo ago · 1 role
Cure51Seed $16.2M · 2 yr ago
CorWaveSeries C $65.9M · 3 yr ago · 3 roles
DeepcSeries A $13M · 3 yr ago
Chroma Bio, Inc.Venture round $135M · 3 yr ago
InspirnaVenture round $55.1M · 4 yr ago
Prometheus MaterialsVenture round $4.1M · 4 yr ago
Mainstay MedicalVenture round $108M · 5 yr ago · 6 roles
CorVent MedicalVenture round $4.5M · 6 yr ago
MaxCyteVenture round $760k · 10 yr ago
Medtronic796 roles
Ascendis Pharma20 roles
Galvanize Therapeutics® Inc9 roles
DBV Technologies5 roles
Avantium4 roles
HAYA Therapeutics3 roles
DNA Script2 roles
iOmx Therapeutics2 roles
GlycoEra1 role
Overview
Sofinnova Partners is a life sciences venture capital firm investing in innovation worldwide. It backs companies in biopharma, medical technology, digital medicine and industrial biotechnology, from early-stage company creation through later-stage crossover rounds. Founded in 1972, it is one of the oldest venture capital firms in Europe and is headquartered in Paris, France, with a team spanning several European countries.
News
Sofinnova Partners closes oversubscribed €82 million MD Start IV fund to build new MedTech startups
Sofinnova Partners, a Paris-based life sciences investor, has closed its Sofinnova MD Start IV fund at €82 million. The firm said the fund was oversubscribed and will build on a strategy dating back to 2008 that has created around a dozen companies. "Sofi
Read more
Report
Sofinnova Partners closes oversubscribed €82M Sofinnova MD Start IV fund
European life sciences venture capital firmSofinnova Partners has closed its fourth medtech fund, Sofinnova MD Start IV,at €82 million. The oversubscribed fund will expand Sofinnova's medtechcompany-c...
Read more
Report
People

Henrijette Richter
Directeur Général

Graziano Seghezzi
Directeur de la publication
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
3
Hiring now
0
Countries
3
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Paris
France
HQ
Sofinnova Partners
7-11 Boulevard Haussmann, Paris, France, 75009, Paris
London
United Kingdom
Regional office
Sofinnova Partners
50 York Way, London, UK, N1 9AB,, London
Milan
Italy
Regional office
Sofinnova Partners
Via Borgogna 5, Milan, Italy, 20122, Milan
Financials
Est. Annual Revenue
$45.4M
2023
